Fennec Pharmaceuticals (FENC) Net Margin Growth (3y) (2023)

Fennec Pharmaceuticals (FENC) Net Margin Growth (3y) (2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Oculis Holding AG 67,102.16 Bn 67,101.87 Bn - -
2 Nanobiotix 1,909.44 Bn 1,909.38 Bn - -
3 Akari Therapeutics 989.71 Bn 989.71 Bn - -
4 BeOne Medicines 471.58 Bn 466.79 Bn 1.35 Bn 9,283.00
5 Vertex Pharmaceuticals 121.97 Bn 114.72 Bn 2.59 Bn 506.00
6 Regeneron Pharmaceuticals 69.93 Bn 61.18 Bn 3.31 Bn -569.00
7 Belite Bio 62.68 Bn 62.68 Bn - -
8 Argenx Se 55.80 Bn 50.61 Bn 1.41 Bn 6,537.00
9 Alnylam Pharmaceuticals 37.37 Bn 34.36 Bn 959.66 Mn 7,218.00
10 Fennec Pharmaceuticals 293.91 Mn 257.13 Mn 12.01 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 1.72 Mn